Basilea Pharmaceutica (CHIX:BSLNZ) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:BSLNZ Basilea Pharmaceutica Ltd CHIX:BSLNZ
65 GF Score
Price CHF51.90
GF Value CHF58.15
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Basilea Pharmaceutica FFO?

FFO (Funds from operations) only applies to REITs.

CHIX:BSLNZ
65GF Score
Basilea Pharmaceutica Ltd CHIX:BSLNZ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Basilea Pharmaceutica (CHIX:BSLNZ) Overvalued in 2026?

Based on GuruFocus' analysis, Basilea Pharmaceutica stock appears to be undervalued. The current stock price of CHF51.90 is trading 10.7% below its estimated GF Value™ of CHF58.15. GuruFocus considers Basilea Pharmaceutica to be Modestly Undervalued.

Key valuation signals for CHIX:BSLNZ:

  • FFO:
  • GF Value™: CHF58.15 vs. price of CHF51.90 (10.7% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the CHIX:BSLNZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Basilea Pharmaceutica Business Description

Address Hegenheimermattweg 167b, Allschwil, CHE, 4123
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.
65GF Score

Get the complete analysis for CHIX:BSLNZ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF51.90
Price
CHF58.15
GF Value